uuid: 34a2c89b-9223-4ba5-aa6a-534c6eb078b8
langcode: en
status: open
dependencies: {  }
open: null
close: null
weight: 0
uid: null
template: false
archive: false
id: tra
title: 'TRAIN Application'
description: ''
category: ''
elements: |-
  container:
    '#type': container
    '#attributes':
      class:
        - 'container my-5'
    custom_text:
      '#type': processed_text
      '#display_on': both
      '#text': |
        <h1>TRAIN Application</h1>

        <p><a href="/centers/fastercures/train">The Research Acceleration and Innovation Network (TRAIN)</a> was established by FasterCures in 2005 to recognize organizations that are pioneering principles of venture philanthropy to catalyze development of new therapies and cures, and to encourage more foundations to adopt such approaches to de-risk translation and commercialization of research in their respective disease areas. Organizations participating in TRAIN have found it a valuable platform for learning from the experiences and practices of other nonprofit research funders and for building relationships with stakeholders in industry, academia, government, and finance. There is no cost to participating in or applying to TRAIN.</p>

        <p>While the organizations that participate in TRAIN are individually unique, all TRAIN organizations demonstrate an ongoing commitment to<strong> accountability</strong>,<strong> collaboration</strong>,<strong> research effectiveness</strong>, <strong>resource building</strong>, and <strong>patient centeredness</strong>. The criteria for participation are based on a FasterCures' publication Measuring and Improving Impact: A Toolkit for Nonprofit Funders of Medical Research, which was intended to provide nonprofit disease research organizations with a self-evaluation framework by which to assess and improve organizational effectiveness.</p>

        <p>Through the questions below, please describe and give examples of the ways in which your organization demonstrates an ongoing commitment to the characteristics that make TRAIN a unique network. The examples provided after questions are meant to underscore the variety of activities that meet the requirements of each category. Innovative and new methods of demonstrating commitment to the TRAIN characteristics are welcomed.</p>

        <p>We estimate the form will take 20-45 minutes to complete. Once you begin to enter information into the online form, you will not be able to save your work and return to it later. You may want to draft your responses in another format first, then copy and paste them into the form.</p>

        <p>If you have any questions, please don't hesitate to contact <a href="mailto:train@milkeninstitute.org">train@milkeninstitute.org</a>. Thank you for your interest in TRAIN!</p>
      '#format': full_html
    first_name:
      '#type': textfield
      '#title': 'First Name'
      '#required': true
    last_name:
      '#type': textfield
      '#title': 'Last Name'
      '#required': true
    title:
      '#type': textfield
      '#title': Title
      '#required': true
    organization:
      '#type': textfield
      '#title': Organization
      '#required': true
    email:
      '#type': email
      '#title': Email
    phone:
      '#type': tel
      '#title': Phone
      '#required': true
    website:
      '#type': textfield
      '#title': Website
    address:
      '#type': webform_address
      '#title': Address
      '#title_display': none
      '#wrapper_attributes':
        class:
          - my-5
      '#attributes':
        class:
          - testclass
      '#format_attributes':
        class:
          - test-display-class
      '#address__placeholder': Address
      '#address__title_display': before
      '#address__required': true
      '#address_2__access': false
      '#city__placeholder': City/Town
      '#city__title_display': invisible
      '#city__required': true
      '#state_province__placeholder': State/Province
      '#state_province__title_display': invisible
      '#state_province__required': true
      '#state_province__type': textfield
      '#postal_code__placeholder': 'ZIP/Postal Code'
      '#postal_code__title_display': invisible
      '#postal_code__required': true
      '#country__placeholder': Country
      '#country__title_display': invisible
      '#country__required': true
    staff:
      '#type': radios
      '#title': Staff
      '#description': 'How many full or part-time professional staff does your organization employ?'
      '#description_display': before
      '#options':
        0: '0'
        1-10: 1-10
        11-50: 11-50
        51-100: 51-100
        101-250: 101-250
        251-500: 251-500
        'More than 500': 'More than 500'
      '#required': true
      '#wrapper_attributes':
        class:
          - 'ml-4 my-5'
    total_expenditures:
      '#type': radios
      '#title': 'Total Expenditures'
      '#description': 'In the most recent fiscal year for which you have data, what were your organization&#39;s annual expenditures on all activities?'
      '#description_display': before
      '#options':
        '<$100,000': '<$100,000'
        '$100,000-$999,999': '$100,000-$999,999'
        '$1,000,000-$1,999,999': '$1,000,000-$1,999,999'
        '2,000,000-$9,999,999': '2,000,000-$9,999,999'
        '$10,000,000-$100,000,000': '$10,000,000-$100,000,000'
        '>$100,000,000': '>$100,000,000'
      '#required': true
      '#wrapper_attributes':
        class:
          - 'ml-4 my-5'
    expenditures:
      '#type': radios
      '#title': Expenditures
      '#description': 'In the most recent fiscal year for which you have data, what were your organization&#39;s annual expenditures devoted to research?'
      '#description_display': before
      '#options':
        '<$100,000': '<$100,000'
        '$100,000-$999,999': '$100,000-$999,999'
        '$1,000,000-$1,999,999': '$1,000,000-$1,999,999'
        '2,000,000-$9,999,999': '2,000,000-$9,999,999'
        '$10,000,000-$100,000,000': '$10,000,000-$100,000,000'
        '>$100,000,000': '>$100,000,000'
      '#required': true
      '#wrapper_attributes':
        class:
          - 'ml-4 my-5'
    background_questions:
      '#type': processed_text
      '#display_on': both
      '#text': |
        <h4>Background Questions</h4>
      '#format': full_html
    why_does_your_organization_want_to_join_train_:
      '#type': textarea
      '#title': 'Why does your organization want to join TRAIN?'
      '#description': '(Please limit this to 250 words or 2000 characters)'
      '#counter_type': character
      '#counter_minimum': 1
      '#counter_maximum': 2000
      '#wrapper_attributes':
        class:
          - 'mt-3 mb-5'
      '#label_attributes':
        class:
          - font-weight-bold
    what_does_your_organization_hope_to_learn_or_accomplish_as_a_mem:
      '#type': textarea
      '#title': 'What does your organization hope to learn or accomplish as a member of TRAIN?'
      '#description': '(Please limit this to 250 words or 2000 characters)'
      '#counter_type': character
      '#counter_minimum': 1
      '#counter_maximum': 2000
      '#wrapper_attributes':
        class:
          - my-5
      '#label_attributes':
        class:
          - font-weight-bold
    what_can_other_train_member_organizations_learn_from_your_organi:
      '#type': textarea
      '#title': 'What can other TRAIN member organizations learn from your organization?'
      '#description': '(Please limit this to 250 words or 2000 characters)'
      '#counter_type': character
      '#counter_minimum': 1
      '#counter_maximum': 2000
      '#wrapper_attributes':
        class:
          - my-5
      '#label_attributes':
        class:
          - font-weight-bold
    accountability:
      '#type': textarea
      '#title': Accountability
      '#description': |-
        How does your organization remain accountable to your mission? How do you engage in planning, demonstrate transparency, and uphold stakeholder responsibility?<br />
        <br />
        Examples may include conducting regular strategic planning and monitoring, employing milestones to measure and manage staff and grantees, having policies in place to promote knowledge sharing as well as technology commercialization, and actively engaging with internal and external experts to gain objective guidance and monitor progress.<br />
        <br />
        (Please limit this to 250 words or 2000 characters)
      '#description_display': before
      '#counter_type': character
      '#counter_minimum': 1
      '#counter_maximum': 2000
      '#wrapper_attributes':
        class:
          - my-5
      '#label_attributes':
        class:
          - h4
    collaboration:
      '#type': textarea
      '#title': Collaboration
      '#description': |-
        Describe the collaborative activities your organization undertakes. Indicate examples of engaging in and nurturing relationships with a wide range of partners that can accelerate the overall funding and research cycle.<br />
        <br />
        Examples may include arrangements with industry to support product development, policies and practices that facilitate data- and knowledge-sharing among researchers and with other stakeholders, participating in research consortia, funding team science and multidisciplinary projects, and funding or collaborating on international research initiatives.<br />
        <br />
        (Please limit this to 250 words or 2000 characters)
      '#description_display': before
      '#counter_type': character
      '#counter_minimum': 1
      '#counter_maximum': 2000
      '#wrapper_attributes':
        class:
          - my-5
      '#label_attributes':
        class:
          - h4
    research_effectiveness:
      '#type': textarea
      '#title': 'Research Effectiveness'
      '#description': |-
        How does your research portfolio yield data and deliverables to achieve your mission? What outcomes has your financial support created?<br />
        <br />
        Examples may include generation of new data, knowledge, and scientific deliverables that address the needs of the field, as well as a portfolio that ensures sufficient volume of scientific discoveries and therapeutic candidates moving into later-stage testing (such as funding/supporting translational research).<br />
        <br />
        (Please limit this to 250 words or 2000 characters)
      '#description_display': before
      '#counter_type': character
      '#counter_minimum': 1
      '#counter_maximum': 2000
      '#wrapper_attributes':
        class:
          - my-5
      '#label_attributes':
        class:
          - h4
    resource_building:
      '#type': textarea
      '#title': 'Resource Building'
      '#description': |-
        In what ways do you fill critical resource gaps that limit scientific progress in your field?<br />
        <br />
        Examples may include funding creation, maintenance, and expansion of infrastructure and resources such as animal models, biobanks, registries, or clinical trials networks; and funding training and career development programs to develop future generations of researchers in the field.<br />
        <br />
        (Please limit this to 250 words or 2000 characters)
      '#description_display': before
      '#counter_type': character
      '#counter_minimum': 1
      '#counter_maximum': 2000
      '#wrapper_attributes':
        class:
          - my-5
      '#label_attributes':
        class:
          - h4
    patient_centeredness:
      '#type': textarea
      '#title': Patient-Centeredness
      '#description': |-
        Describe ways in which your organization works to make the research and development enterprise more patient-centered. How are the needs of patients, caregivers, and family members understood and reflected in your strategic approaches and programs? How are you working to integrate patient perspectives and priorities with the other stakeholders in the system?<br />
        <br />
        Examples may include connecting patients to relevant clinical trials, educating policymakers about patient priorities and the science in your field, and actively including patients and/or caregivers in organizational governance.<br />
        <br />
        (Please limit this to 250 words or 2000 characters)
      '#description_display': before
      '#counter_type': character
      '#counter_minimum': 1
      '#counter_maximum': 2000
      '#wrapper_attributes':
        class:
          - my-5
      '#label_attributes':
        class:
          - h4
    anything_else:
      '#type': textarea
      '#title': 'Anything else'
      '#description': 'Is there anything else that you want us to know?'
      '#description_display': before
      '#wrapper_attributes':
        class:
          - my-5
      '#label_attributes':
        class:
          - h4
    send_copy:
      '#type': checkbox
      '#title': 'Send me a copy of my responses'
      '#description_display': invisible
      '#wrapper_attributes':
        class:
          - 'mx-3 my-5 '
    actions:
      '#type': webform_actions
      '#title': 'Submit button(s)'
      '#attributes':
        class:
          - mx-3
css: ''
javascript: ''
settings:
  ajax: false
  ajax_scroll_top: form
  ajax_progress_type: ''
  ajax_effect: ''
  ajax_speed: null
  page: true
  page_submit_path: /form/train
  page_confirm_path: ''
  page_theme_name: ''
  form_title: both
  form_submit_once: false
  form_exception_message: ''
  form_open_message: ''
  form_close_message: ''
  form_previous_submissions: true
  form_confidential: false
  form_confidential_message: ''
  form_remote_addr: true
  form_convert_anonymous: false
  form_prepopulate: false
  form_prepopulate_source_entity: false
  form_prepopulate_source_entity_required: false
  form_prepopulate_source_entity_type: ''
  form_reset: false
  form_disable_autocomplete: false
  form_novalidate: false
  form_disable_inline_errors: false
  form_required: false
  form_unsaved: false
  form_disable_back: false
  form_submit_back: false
  form_autofocus: false
  form_details_toggle: false
  form_access_denied: default
  form_access_denied_title: ''
  form_access_denied_message: ''
  form_access_denied_attributes: {  }
  form_file_limit: ''
  share: false
  share_node: false
  share_theme_name: ''
  share_title: true
  share_page_body_attributes: {  }
  submission_label: ''
  submission_log: false
  submission_views: {  }
  submission_views_replace: {  }
  submission_user_columns: {  }
  submission_user_duplicate: false
  submission_access_denied: default
  submission_access_denied_title: ''
  submission_access_denied_message: ''
  submission_access_denied_attributes: {  }
  submission_exception_message: ''
  submission_locked_message: ''
  submission_excluded_elements: {  }
  submission_exclude_empty: false
  submission_exclude_empty_checkbox: false
  previous_submission_message: ''
  previous_submissions_message: ''
  autofill: false
  autofill_message: ''
  autofill_excluded_elements: {  }
  wizard_progress_bar: true
  wizard_progress_pages: false
  wizard_progress_percentage: false
  wizard_progress_link: false
  wizard_progress_states: false
  wizard_auto_forward: true
  wizard_start_label: ''
  wizard_preview_link: false
  wizard_confirmation: true
  wizard_confirmation_label: ''
  wizard_track: ''
  wizard_prev_button_label: ''
  wizard_next_button_label: ''
  wizard_toggle: false
  wizard_toggle_show_label: ''
  wizard_toggle_hide_label: ''
  preview: 0
  preview_label: ''
  preview_title: ''
  preview_message: ''
  preview_attributes: {  }
  preview_excluded_elements: {  }
  preview_exclude_empty: true
  preview_exclude_empty_checkbox: false
  draft: none
  draft_multiple: false
  draft_auto_save: false
  draft_saved_message: ''
  draft_loaded_message: ''
  draft_pending_single_message: ''
  draft_pending_multiple_message: ''
  confirmation_type: page
  confirmation_title: ''
  confirmation_message: ''
  confirmation_url: ''
  confirmation_attributes: {  }
  confirmation_back: true
  confirmation_back_label: ''
  confirmation_back_attributes: {  }
  confirmation_exclude_query: false
  confirmation_exclude_token: false
  confirmation_update: false
  limit_total: null
  limit_total_interval: null
  limit_total_message: ''
  limit_total_unique: false
  limit_user: null
  limit_user_interval: null
  limit_user_message: ''
  limit_user_unique: false
  entity_limit_total: null
  entity_limit_total_interval: null
  entity_limit_user: null
  entity_limit_user_interval: null
  purge: none
  purge_days: null
  results_disabled: false
  results_disabled_ignore: false
  results_customize: false
  token_view: false
  token_update: false
  form_disable_remote_addr: false
  wizard_auto_forward_hide_next_button: false
  wizard_keyboard: true
  token_delete: false
  serial_disabled: false
access:
  create:
    roles:
      - anonymous
      - authenticated
    users: {  }
    permissions: {  }
  view_any:
    roles: {  }
    users: {  }
    permissions: {  }
  update_any:
    roles: {  }
    users: {  }
    permissions: {  }
  delete_any:
    roles: {  }
    users: {  }
    permissions: {  }
  purge_any:
    roles: {  }
    users: {  }
    permissions: {  }
  view_own:
    roles: {  }
    users: {  }
    permissions: {  }
  update_own:
    roles: {  }
    users: {  }
    permissions: {  }
  delete_own:
    roles: {  }
    users: {  }
    permissions: {  }
  administer:
    roles: {  }
    users: {  }
    permissions: {  }
  test:
    roles: {  }
    users: {  }
    permissions: {  }
  configuration:
    roles: {  }
    users: {  }
    permissions: {  }
handlers: {  }
variants: {  }
